{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:43Z","timestamp":1786982203928,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02238-9","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T11:02:20Z","timestamp":1702292540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Short-term pain control after palliative radiotherapy for uncomplicated bone metastases: a prospective cohort study"],"prefix":"10.1007","volume":"41","author":[{"given":"Sofia Paola","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Faccenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Parma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Saufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"De Ponti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Panizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-8876","authenticated-orcid":false,"given":"Stefano","family":"Arcangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"issue":"3","key":"2238_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165\u201376. https:\/\/doi.org\/10.1053\/ctrv.2000.0210.","journal-title":"Cancer Treat Rev"},{"key":"2238_CR2","doi-asserted-by":"publisher","first-page":"115783","DOI":"10.1016\/j.bone.2020.115783","volume":"158","author":"C Ryan","year":"2022","unstructured":"Ryan C, Stoltzfus KC, Horn S, Chen H, Louie AV, Lehrer EJ, Trifiletti DM, Fox EJ, Abraham JA, Zaorsky NG. Epidemiology of bone metastases. Bone. 2022;158:115783. https:\/\/doi.org\/10.1016\/j.bone.2020.115783.","journal-title":"Bone"},{"issue":"5","key":"2238_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2217\/fon-2018-0613","volume":"15","author":"GT Silva","year":"2019","unstructured":"Silva GT, Silva LM, Bergmann A, Thuler LC. Bone metastases and skeletal-related events: incidence and prognosis according to histological subtype of lung cancer. Future Oncol. 2019;15(5):485\u201394. https:\/\/doi.org\/10.2217\/fon-2018-0613.","journal-title":"Future Oncol"},{"issue":"9","key":"2238_CR4","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437\u201349. https:\/\/doi.org\/10.1093\/annonc\/mdm056.","journal-title":"Ann Oncol"},{"issue":"16","key":"2238_CR5","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1200\/jco.2011.39.2381","volume":"30","author":"MJ Fisch","year":"2012","unstructured":"Fisch MJ, Lee JW, Weiss M, et al. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012;30(16):1980\u20138. https:\/\/doi.org\/10.1200\/jco.2011.39.2381.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2238_CR6","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","volume":"19","author":"S Deandrea","year":"2008","unstructured":"Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985\u201391. https:\/\/doi.org\/10.1093\/annonc\/mdn419.","journal-title":"Ann Oncol"},{"issue":"3","key":"2238_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11916-000-0078-3","volume":"4","author":"C Ripamonti","year":"2000","unstructured":"Ripamonti C, Fulfaro F. Malignant bone pain: pathophysiology and treatments. Curr Rev Pain. 2000;4(3):187\u201396. https:\/\/doi.org\/10.1007\/s11916-000-0078-3.","journal-title":"Curr Rev Pain"},{"issue":"1","key":"2238_CR8","first-page":"65","volume":"45","author":"C Ripamonti","year":"2001","unstructured":"Ripamonti C, Fulfaro F. Pathogenesis and pharmacological treatment of bone pain in skeletal metastases. Q J Nucl Med. 2001;45(1):65\u201377.","journal-title":"Q J Nucl Med"},{"issue":"Suppl 4","key":"2238_CR9","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv166\u201391. https:\/\/doi.org\/10.1093\/annonc\/mdy152.","journal-title":"Ann Oncol."},{"key":"2238_CR10","doi-asserted-by":"publisher","first-page":"6231s","DOI":"10.1158\/1078-0432.ccr-06-0682","volume":"12","author":"MJ Goblirsch","year":"2006","unstructured":"Goblirsch MJ, Zwolak PP, Clohisy DR. Biology of bone cancer pain. Clin Cancer Res. 2006;12:6231s\u20135s. https:\/\/doi.org\/10.1158\/1078-0432.ccr-06-0682.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2238_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11916-012-0271-1","volume":"16","author":"S Lutz","year":"2012","unstructured":"Lutz S. The role of radiation therapy in controlling painful bone metastases. Curr Pain Headache Rep. 2012;16(4):300\u20136. https:\/\/doi.org\/10.1007\/s11916-012-0271-1.","journal-title":"Curr Pain Headache Rep"},{"issue":"5\u20136","key":"2238_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1387\/ijdb.041817lv","volume":"48","author":"LA Vakaet","year":"2004","unstructured":"Vakaet LA, Boterberg T. Pain control by ionizing radiation of bone metastasis. Int J Dev Biol. 2004;48(5\u20136):599\u2013606. https:\/\/doi.org\/10.1387\/ijdb.041817lv.","journal-title":"Int J Dev Biol"},{"issue":"3","key":"2238_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","volume":"126","author":"SE Rich","year":"2018","unstructured":"Rich SE, Chow R, Raman S, et al. Update of the systematic review of palliative radiation therapy fractionation for bone metastases [published correction appears in Radiother Oncol. 2019 Jun; 135:201]. Radiother Oncol. 2018;126(3):547\u201357. https:\/\/doi.org\/10.1016\/j.radonc.2018.01.003.","journal-title":"Radiother Oncol"},{"issue":"11","key":"2238_CR14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1200\/jco.2006.09.5281","volume":"25","author":"E Chow","year":"2007","unstructured":"Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007;25(11):1423\u201336. https:\/\/doi.org\/10.1200\/jco.2006.09.5281.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2238_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.radonc.2008.05.018","volume":"89","author":"P ForoArnalot","year":"2008","unstructured":"ForoArnalot P, Fontanals AV, Galcer\u00e1n JC, et al. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol. 2008;89(2):150\u20135. https:\/\/doi.org\/10.1016\/j.radonc.2008.05.018.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2238_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0167-8140(99)00097-3","volume":"52","author":"On behalf of the Bone Pain Trial Working Party","year":"1999","unstructured":"On behalf of the Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up Bone Pain Trial Working Party. Radiother Oncol. 1999;52(2):111\u201321. https:\/\/doi.org\/10.1016\/S0167-8140(99)00097-3.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2238_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0167-8140(97)00101-1","volume":"45","author":"MN Gaze","year":"1997","unstructured":"Gaze MN, Kelly CG, Kerr GR, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol. 1997;45(2):109\u201316. https:\/\/doi.org\/10.1016\/s0167-8140(97)00101-1.","journal-title":"Radiother Oncol"},{"issue":"3","key":"2238_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/s0360-3016(02)04147-0","volume":"55","author":"JS Wu","year":"2003","unstructured":"Wu JS, Wong R, Johnston M, Bezjak A, Whelan T, Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55(3):594\u2013605. https:\/\/doi.org\/10.1016\/s0360-3016(02)04147-0.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2238_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","volume":"7","author":"S Lutz","year":"2017","unstructured":"Lutz S, Balboni T, Jones J, et al. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017;7(1):4\u201312. https:\/\/doi.org\/10.1016\/j.prro.2016.08.001.","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"2238_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijrobp.2019.07.009","volume":"105","author":"K Spencer","year":"2019","unstructured":"Spencer K, Velikova G, Henry A, Westhoff P, Hall PT, van der Linden YM. Net pain relief after palliative radiation therapy for painful bone metastases: a useful measure to reflect response duration? a further analysis of the dutch bone metastasis study. Int J Radiat Oncol Biol Phys. 2019;105(3):559\u201366. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.07.009.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2238_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s0936-6555(03)00113-4","volume":"15","author":"WM Sze","year":"2003","unstructured":"Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy\u2013a systematic review of randomised trials. Clin Oncol (R Coll Radiol). 2003;15(6):345\u201352. https:\/\/doi.org\/10.1016\/s0936-6555(03)00113-4.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10","key":"2238_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/jnci\/djz101","volume":"111","author":"KL Spencer","year":"2019","unstructured":"Spencer KL, van der Velden JM, Wong E, et al. Systematic review of the role of stereotactic radiotherapy for bone metastases. J Natl Cancer Inst. 2019;111(10):1023\u201332. https:\/\/doi.org\/10.1093\/jnci\/djz101.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2238_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.clon.2022.02.005","volume":"34","author":"EM Dunne","year":"2022","unstructured":"Dunne EM, Liu MC, Lo SS, Sahgal A. The changing landscape for the treatment of painful spinal metastases: is stereotactic body radiation therapy the new standard of care? Clin Oncol (R Coll Radiol). 2022;34(5):325\u201331. https:\/\/doi.org\/10.1016\/j.clon.2022.02.005.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"2238_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijrobp.2020.12.045","volume":"110","author":"M Guckenberger","year":"2021","unstructured":"Guckenberger M, Mantel F, Sweeney RA, et al. Long-term results of dose-intensified fractionated stereotactic body radiation therapy (SBRT) for painful spinal metastases. Int J Radiat Oncol Biol Phys. 2021;110(2):348\u201357. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.045.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2238_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.0356","author":"S Ryu","year":"2023","unstructured":"Ryu S, Deshmukh S, Timmerman RD, et al. Stereotactic radiosurgery vs conventional radiotherapy for localized vertebral metastases of the spine: phase 3 results of NRG oncology\/RTOG 0631 randomized clinical trial. JAMA Oncol. 2023. https:\/\/doi.org\/10.1001\/jamaoncol.2023.0356.","journal-title":"JAMA Oncol"},{"issue":"7","key":"2238_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1470-2045(21)00196-0","volume":"22","author":"A Sahgal","year":"2021","unstructured":"Sahgal A, Myrehaug SD, Siva S, et al. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial. Lancet Oncol. 2021;22(7):1023\u201333. https:\/\/doi.org\/10.1016\/s1470-2045(21)00196-0.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2238_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","volume":"128","author":"T Sprave","year":"2018","unstructured":"Sprave T, Verma V, F\u00f6rster R, et al. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiother Oncol. 2018;128(2):274\u201382. https:\/\/doi.org\/10.1016\/j.radonc.2018.04.030.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2238_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijrobp.2020.11.060","volume":"110","author":"BJ Pielkenrood","year":"2021","unstructured":"Pielkenrood BJ, van der Velden JM, van der Linden YM, et al. Pain response after stereotactic body radiation therapy versus conventional radiation therapy in patients with bone metastases-a phase 2 randomized controlled trial within a prospective cohort. Int J Radiat Oncol Biol Phys. 2021;110(2):358\u201367. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.060.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2238_CR29","doi-asserted-by":"publisher","unstructured":"Nguyen QN, Chun SG, Chow E, et al. Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 Trial [published correction appears in JAMA Oncol. 2021 Oct 1;7(10):1581]. JAMA Oncol. 5(6):872-878. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0192","DOI":"10.1001\/jamaoncol.2019.0192"},{"issue":"3 Suppl","key":"2238_CR30","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Constine LS, Deasy JO, et al. Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S3\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.040.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2238_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","volume":"34","author":"P Diez","year":"2022","unstructured":"Diez P, Hanna GG, Aitken KL, et al. UK 2022 Consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy. Clin Oncol (R Coll Radiol). 2022;34(5):288\u2013300. https:\/\/doi.org\/10.1016\/j.clon.2022.02.010.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2238_CR32","unstructured":"US Department of Health And Human Services, et al. Common terminology criteria for adverse events. Version 5.0. 2020."},{"issue":"5","key":"2238_CR33","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.ijrobp.2011.02.008","volume":"82","author":"E Chow","year":"2012","unstructured":"Chow E, Hoskin P, Mitera G, et al. Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys. 2012;82(5):1730\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.02.008.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2238_CR34","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singap"},{"key":"2238_CR35","unstructured":"Nielsen, S., Degenhardt, L., Hoban, B. and Gisev, N.(2014). Comparing opioids: A guide to estimating oral morphine equivalents (OME) in research. Technical Report No. 329 Sydney: National Drug and Alcohol Research Centre, University of NSW."},{"issue":"2","key":"2238_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semradonc.2022.11.006","volume":"33","author":"M Guckenberger","year":"2023","unstructured":"Guckenberger M, Dahele M, Ong WL, Sahgal A. Stereotactic body radiation therapy for spinal metastases: benefits and limitations. Semin Radiat Oncol. 2023;33(2):159\u201371. https:\/\/doi.org\/10.1016\/j.semradonc.2022.11.006.","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"2238_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.prro.2018.11.006","volume":"9","author":"T Saito","year":"2019","unstructured":"Saito T, Toya R, Oya N. Pain response rates after conventional radiation therapy for bone metastases in prospective nonrandomized studies: a systematic review. Pract Radiat Oncol. 2019;9(2):81\u20138. https:\/\/doi.org\/10.1016\/j.prro.2018.11.006.","journal-title":"Pract Radiat Oncol"},{"key":"2238_CR38","doi-asserted-by":"publisher","unstructured":"Cacicedo J, G\u00f3mez-Iturriaga A, Navarro A, et al. 2018 Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter? [published online ahead of print, 2018 May 23]. J Med Imaging Radiat Oncol. https:\/\/doi.org\/10.1111\/1754-9485.12749","DOI":"10.1111\/1754-9485.12749"},{"issue":"1","key":"2238_CR39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2036","volume":"10","author":"M Shuja","year":"2018","unstructured":"Shuja M, Elghazaly AA, Iqbal A, et al. Efficacy of 8 Gy single fraction palliative radiation therapy in painful bone metastases: a single institution experience. Cureus. 2018;10(1): e2036. https:\/\/doi.org\/10.7759\/cureus.2036.","journal-title":"Cureus"},{"issue":"20","key":"2238_CR40","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1056\/nejmra025411","volume":"349","author":"JC Ballantyne","year":"2003","unstructured":"Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349(20):1943\u201353. https:\/\/doi.org\/10.1056\/nejmra025411.","journal-title":"N Engl J Med"},{"issue":"6\u20137","key":"2238_CR41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.canrad.2021.06.021","volume":"25","author":"E Rapeaud","year":"2021","unstructured":"Rapeaud E, Meynard C, Lecante F, Durdux C. M\u00e9tastases osseuses: efficacit\u00e9 et modalit\u00e9s de prescription de la radioth\u00e9rapie classique [Bone metastasis: Efficacy and technical modalities of classical radiotherapy]. Cancer Radiother. 2021;25(6\u20137):707\u201312. https:\/\/doi.org\/10.1016\/j.canrad.2021.06.021.","journal-title":"Cancer Radiother"},{"key":"2238_CR42","doi-asserted-by":"publisher","unstructured":"van der Velden JM, Peters M, Verlaan JJ, et al. 2017 Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases [published correction appears in Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1186]. Int J Radiat Oncol Biol Phys. 99(4): 859-866. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.029","DOI":"10.1016\/j.ijrobp.2017.07.029"},{"issue":"1","key":"2238_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2217\/pmt-2018-0031","volume":"9","author":"D Magee","year":"2019","unstructured":"Magee D, Bachtold S, Brown M, Farquhar-Smith P. Cancer pain: where are we now? Pain Manag. 2019;9(1):63\u201379. https:\/\/doi.org\/10.2217\/pmt-2018-0031.","journal-title":"Pain Manag"},{"issue":"11","key":"2238_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12032-021-01587-7","volume":"38","author":"R Kapoor","year":"2021","unstructured":"Kapoor R, Saxena AK, Vasudev P, Sundriyal D, Kumar A. Cancer induced bone pain: current management and future perspectives. Med Oncol. 2021;38(11):134. https:\/\/doi.org\/10.1007\/s12032-021-01587-7.","journal-title":"Med Oncol"},{"issue":"6","key":"2238_CR45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/cancers10060156","volume":"10","author":"T Kimura","year":"2018","unstructured":"Kimura T. Multidisciplinary approach for bone metastasis: a review. Cancers (Basel). 2018;10(6):156. https:\/\/doi.org\/10.3390\/cancers10060156.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2238_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.prro.2016.09.008","volume":"7","author":"S Raman","year":"2017","unstructured":"Raman S, Chow R, Hoskin P, Chow E. How should radiation oncologists interpret the ASTRO evidence-based guideline and ASTRO Choosing Wisely campaign for the treatment of uncomplicated bone metastases? Pract Radiat Oncol. 2017;7(1):13\u20135. https:\/\/doi.org\/10.1016\/j.prro.2016.09.008.","journal-title":"Pract Radiat Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02238-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02238-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02238-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T05:16:51Z","timestamp":1704691011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02238-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["2238"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02238-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This is an observational study and no ethical approval is required.<b>Informed consent<\/b>Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"13"}}